2 completed, 1 recruiting. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Recruiting 1 |
| Phase 1 | 1 | Completed 1 |
Follow Primary Mediastinal B-cell Lymphoma: new trials by email Literature Review of Primary Mediastinal B-cell Lymphoma trials Research Report on Primary Mediastinal B-cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Obinutuzumab and ICE Chemotherapy in Refractory/Recurrent CD20+ Mature NHL Obinutuzumab, Liposomal ARA-C, Ifosfamide - Non-Hodgkin Lymphoma, Burkitt Lymphoma | Phase 2 | Recruiting | New York Medical College | 25 | 2015-08-21 | 2026-10-23 |
| CAR T Cell Receptor Immunotherapy for Patients With B-cell Lymphoma Fludarabine, Cyclophosphamide, Anti-cluster of differentiation 19 (CD19)-CAR PBL - Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 43 | 2009-02-17 | 2022-01-12 |
| R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas immunotherapy, Induction treatment part 1, Induction treatment part 2 with PBPC collection - Diffuse Large B-Cell Lymphoma., Primary Mediastinal B-Cell Lymphoma | Phase 2 | Completed | Czech Lymphoma Study Group | 106 | 2002-05-01 | 2007-11-14 |
Lymphoma, Large B-Cell, Diffuse (2) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Leukemia (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Follicular (1) · Lymphoma, Non-Hodgkin (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Lymphoma (2) · Chronic Disease (1) · DNA Virus Infections (1) · Disease Attributes (1) · Epstein-Barr Virus Infections (1) · Hematologic Diseases (1) · Herpesviridae Infections (1) · Histiocytic Disorders, Malignant (1)
Carboplatin (1) · Cyclophosphamide (1) · Etoposide (1) · Ifosfamide (1) · Immunotherapy (1) · Interleukin-2 (1) · aldesleukin (1) · fludarabine (1) · fludarabine phosphate (1) · obinutuzumab (1)
Czech Lymphoma Study Group (1) · National Cancer Institute (NCI) (1) · New York Medical College (1)
United States (2) · Czechia (1)
Mitchell Cairo, MD (1) · Pytlik Robert, M.D. (1) · Steven A Rosenberg, M.D., Ph.D. (1)
PMID 20668228, PMID 22160384, PMID 23546520, PMID 24055823, PMID 25154820, PMID 28291388, PMID 28803861, PMID 29895668, PMID 33021872, PMID 34515338